Skip to main content

View full-text article in PMC

. 2019 Jun 4;9:157. doi: 10.1038/s41398-019-0489-3

Table 4.

Cox regression analyses of mAge acceleration versus mortality in schizophrenia and controls after excluding individuals with pre-existing cancer

	SCZ-died (n = 83) vs. SCZ-alive (n = 56)		SCZ-died (n = 83) vs. Controls-alive (n = 56)		SCZ-died (n = 83) vs. Controls-died (n = 53)
	Unadjusted	Adjusted^a	Unadjusted	Adjusted^a	Unadjusted	Adjusted^a
Hannum	1.06 (0.98–1.14); p = 0.09	1.13 (1.04–1.22); p = 0.005	1.04 (0.97–1.10); p = 0.27	1.10 (1.01–1.19); p = 0.02	1.03 (0.99–1.08); p = 0.18	1.05 (0.98–1.11); p = 0.12
Horvath	1.04 (0.97–1.10); p = 0.28	1.06 (0.99–1.13); p = 0.08	1.00 (0.95–1.07); p = 0.89	1.06 (0.99–1.14); p = 0.08	1.00 (0.96–1.04); p = 0.96	1.01 (0.97–1.06); p = 0.55
Levine	1.01 (0.97–1.07); p = 0.44	1.01 (0.96–1.07); p = 0.63	1.03 (0.98–1.08); p = 0.25	0.99 (0.94–1.05); p = 0.76	0.99 (0.96–1.04); p = 0.91	0.98 (0.94–1.03); p = 0.56

Values are Hazard Ratios (95% Confidence Intervals) and p-values

^aAdjusted for white blood cell counts, age, sex, smoking score, and methylation batch